83. Addison disease
20 clinical trials,   42 drugs   (DrugBank: 13 drugs),   6 drug target genes,   17 drug target pathways

Searched query = "Addison disease", "Primary chronic adrenocortical insufficiency", "Autoimmune polyglandular syndrome", "Hypoparathyroidism-Addison-Monilia syndrome", "HAM syndrome", "Schmidt syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2015-001090-40-GB
(EUCTR)
22/06/201508/04/2015The effects of two brands of hydrocortisone injected intramuscularly into deltoid and thigh musclesAn open label pilot study to investigate the effects of two preparations of hydrocortisone (Hydrocortisone 100mg/ml and Solu-Cortef) injected intramuscularly into the deltoid and upper thigh muscle during the state of hypocortisolaemia - Effects of 100mg Hydrocortisone injection into Deltoid & Thigh Addison's Disease
MedDRA version: 20.1;Level: PT;Classification code 10001130;Term: Addison's disease;System Organ Class: 10014698 - Endocrine disorders;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]
Trade Name: Solu-Cortef
Product Name: Solu-Cortef
INN or Proposed INN: Hydrocortisone
Trade Name: Hydrocortisone 100mg/ml
Product Name: Hydrocortisone 100mg/ml
INN or Proposed INN: Hydrocortisone
The London ClinicNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
8Phase 4United Kingdom